Biomerica, Inc. (NASDAQ:BMRA) Short Interest Update

Biomerica, Inc. (NASDAQ:BMRA) was the recipient of a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 254,500 shares, a decline of 7.6% from the January 15th total of 275,500 shares. Based on an average daily volume of 7,530,000 shares, the short-interest ratio is presently 0.0 days.

Institutional Investors Weigh In On Biomerica

An institutional investor recently raised its position in Biomerica stock. Granahan Investment Management LLC increased its position in Biomerica, Inc. (NASDAQ:BMRA) by 24.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 658,767 shares of the company’s stock after acquiring an additional 131,306 shares during the period. Granahan Investment Management LLC owned approximately 3.59% of Biomerica worth $198,000 at the end of the most recent reporting period. 22.28% of the stock is owned by institutional investors.

Biomerica Stock Performance

Shares of Biomerica stock traded up $0.05 during trading hours on Monday, reaching $0.83. The company’s stock had a trading volume of 1,647,841 shares, compared to its average volume of 21,378,354. Biomerica has a one year low of $0.24 and a one year high of $1.35. The company’s 50 day simple moving average is $0.45 and its 200 day simple moving average is $0.38. The stock has a market cap of $15.22 million, a P/E ratio of -2.44 and a beta of -0.98.

Biomerica (NASDAQ:BMRA) last issued its earnings results on Tuesday, January 14th. The company reported ($0.06) EPS for the quarter. Biomerica had a negative net margin of 100.52% and a negative return on equity of 90.19%.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.